BB Biotech Ventures
Overview
BB Biotech Ventures is a Guernsey based healthcare venture capital firm focusing on investments in growth capital or earlier-stage technology platform companies. Its primary areas of investment include biotechnology, pharmaceutical, and medical device companies.
Investment Focus
- Innovative drug development
- Medical device innovation
- Strong management team
- Scalable business model
- Clear regulatory pathway
- Potential for significant market impact
- Alignment with healthcare investment trends
- Commitment to improving patient outcomes
- Ability to attract follow-on funding
- Strategic fit with existing portfolio companies
- Demonstrated clinical or preclinical efficacy
- Robust intellectual property portfolio
- Clear exit strategy
- Regulatory compliance
- Ethical business practices
- Sustainable competitive advantage
- Scalable manufacturing capabilities
- Strong intellectual property protection
- Clear commercialization strategy
Reach BB Biotech Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about BB Biotech Ventures
What sectors does BB Biotech Ventures invest in?
BB Biotech Ventures invests in Health Care, Pharmaceuticals, Medical Devices, Biotechnology, Therapeutics and Women's Health, and is based in Zurich, Switzerland. BB Biotech Ventures is listed as a vc in the ConnectSafely investor database.
What stage does BB Biotech Ventures invest at?
BB Biotech Ventures backs companies at Early Stage and Late Stage.
Which regions does BB Biotech Ventures invest in?
BB Biotech Ventures invests across United States, Germany, Switzerland, Ireland and Netherlands.
Last updated · Source: ConnectSafely investor database
